Sample Fingernail Drug Test Report
Below is a representative fingernail drug test report for a 35-year-old male, incorporating standard collection protocols, analytical methodology, and interpretation guidelines based on validated forensic toxicology practices 1, 2, 3.
LABORATORY REPORT: FINGERNAIL DRUG ANALYSIS
Patient Information:
- Name: [Redacted]
- Age: 35 years
- Sex: Male
- Date of Birth: [MM/DD/YYYY]
- Collection Date: [MM/DD/YYYY]
- Report Date: [MM/DD/YYYY]
Specimen Details:
- Matrix: Fingernail clippings
- Collection Method: All 10 fingernails clipped 2-3 mm from free edge
- Total Weight: 105 mg
- Appearance: Normal keratin, no visible contamination
- Chain of Custody: Maintained
ANALYTICAL METHOD
Sample Preparation:
- Washing protocol: Decontamination with methanol to remove external contamination
- Pulverization: Ball mill grinding to homogenize sample
- Digestion: VMA-TM3® buffer reagent for keratin matrix digestion 1
- Extraction: Solid-phase extraction (SPE)
Instrumental Analysis:
- Method: Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) 2, 3
- Column: Reversed-phase C18
- Mobile Phase: 5 mM ammonium formate/acetonitrile gradient
- Detection: Triple quadrupole mass spectrometer, positive electrospray ionization
- Mode: Multiple reaction monitoring (MRM)
Detection Window: 3-6 months retrospective 3, 4
DRUGS SCREENED (76-analyte panel)
Classes Tested:
- Amphetamines (amphetamine, methamphetamine, MDMA, MDA, MDEA)
- Cocaine and metabolites (cocaine, benzoylecgonine, cocaethylene)
- Opioids (morphine, codeine, hydrocodone, oxycodone, hydromorphone, oxymorphone, methadone, EDDP, buprenorphine)
- Cannabinoids (THC, carboxy-THC)
- Benzodiazepines
- Synthetic cathinones (mephedrone, methylone, 4-MEC, methcathinone)
- Ketamine and norketamine
- GHB/GBL
- Barbiturates
- Other psychotropic medications
RESULTS
| Analyte | Result | Concentration (pg/mg) | Cutoff (pg/mg) |
|---|---|---|---|
| Cocaine | POSITIVE | 1,245 | 20 |
| Benzoylecgonine | POSITIVE | 892 | 20 |
| Methamphetamine | POSITIVE | 3,687 | 40 |
| Amphetamine | POSITIVE | 425 | 40 |
| MDMA | NEGATIVE | <40 | 40 |
| Carboxy-THC | POSITIVE | 12.3 | 0.04 |
| Oxycodone | NEGATIVE | <40 | 40 |
| Hydrocodone | NEGATIVE | <40 | 40 |
| Morphine | NEGATIVE | <40 | 40 |
| Methadone | NEGATIVE | <40 | 40 |
| Ethyl glucuronide (EtG) | POSITIVE | 156 | 20 |
| All other analytes | NEGATIVE | Below LOD | — |
INTERPRETATION
Positive Findings:
Cocaine/Benzoylecgonine: Concentrations consistent with repeated cocaine use during the 3-6 month period prior to collection 3. The presence of the metabolite benzoylecgonine confirms systemic exposure rather than external contamination.
Methamphetamine/Amphetamine: Both parent drug and metabolite detected, indicating methamphetamine use within the detection window 5, 3. Concentrations (median range) suggest regular use.
Carboxy-THC: Low-level detection consistent with cannabis exposure 6. Fingernail concentrations are typically higher than hair for cannabinoids, and this level suggests intermittent to regular use.
Ethyl Glucuronide (EtG): Concentration of 156 pg/mg indicates alcohol consumption during the detection period 3. Important caveat: Low-level EtG can result from incidental exposure to hand sanitizers, mouthwash, or other alcohol-containing products 7, though this concentration suggests actual consumption.
Negative Findings:
- No evidence of MDMA, opioids, benzodiazepines, or synthetic drugs during the testing period.
COMMENTS AND LIMITATIONS
Key Considerations:
Detection Window: Fingernails provide a 3-6 month retrospective window, longer than urine (days) but comparable to hair 7, 3, 4.
Concentration Interpretation: Drug concentrations in nails are not directly comparable to hair or blood levels 2, 4. Fingernail concentrations are typically higher than toenails for the same exposure 1, 6.
Incorporation Mechanism: Drugs incorporate into nails primarily during formation at the germinal matrix, with potential contribution from sweat and sebum 2.
External Contamination: The washing protocol minimizes but cannot completely eliminate external contamination, particularly for volatile drugs like THC 7, 2.
Timing Limitations: Unlike segmental hair analysis, fingernails cannot precisely determine when during the 3-6 month window drugs were used 4.
False Negatives: Acidic compounds (e.g., ibuprofen) and some weakly acidic drugs may not be detected in nails 4. Infrequent or single-use exposures may fall below detection limits.
Clinical Context Required: Results must be interpreted alongside complete medical history, prescribed medications, and clinical presentation 7. Drug testing cannot distinguish between appropriate use and misuse of prescribed medications 7.
Sample Adequacy: Minimum 100 mg required for comprehensive multi-drug analysis 3. Insufficient sample may limit testing scope.
Medical Review Officer: [Name, Credentials]
Laboratory Director: [Name, Credentials]
CLIA Certified Laboratory #: [Number]
CAP Accredited
This report is confidential and intended solely for the requesting provider and patient.